PRF Technologies (PRFX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.78, -7.64% vs the prior close of $0.85.
- Volume 6.72K shares, 0.0x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
PRFX slides 7.6% to $0.78, a 52-week low. Closed at $0.78, -7.64% vs the prior close of $0.85. Day range $0.78–$0.83, opened at $0.81.
PRFX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — PRFX slides 7.6% to $0.78, a 52-week low
- Closed at $0.78, -7.64% vs the prior close of $0.85. Day range $0.78–$0.83, opened at $0.81.
- Volume was 6.72K shares, 0.0x its 50-day average of 318.11K — lighter than usual.
- Price is -18.1% vs its 50-day average ($0.95) and -60.6% vs its 200-day average ($1.98).
- 52-week range $0.78–$7.95; today's close sits at 0% of that range, 90.2% below the 52-week high.
Oct 15, 2026 — PRFX jumps 3.3% to $0.85
- Closed at $0.85, +3.30% vs the prior close of $0.82. Day range $0.81–$0.87, opened at $0.82.
- Volume was 36.40K shares, 0.1x its 50-day average of 318.30K — lighter than usual.
- Price is -11.9% vs its 50-day average ($0.96) and -57.6% vs its 200-day average ($1.99).
- 52-week range $0.81–$7.95; today's close sits at 1% of that range, 89.4% below the 52-week high.
Oct 14, 2026 — PRFX ends flat (+0.1%) to $0.82
- Closed at $0.82, +0.12% vs the prior close of $0.82. Day range $0.81–$0.84, opened at $0.83.
- Volume was 55.30K shares, 0.2x its 50-day average of 321.11K — lighter than usual.
- Price is -15.2% vs its 50-day average ($0.97) and -59.2% vs its 200-day average ($2.01).
- 52-week range $0.81–$7.95; today's close sits at 0% of that range, 89.7% below the 52-week high.
Oct 13, 2026 — PRFX slides 4.9% to $0.82, a 52-week low
- Closed at $0.82, -4.88% vs the prior close of $0.86. Day range $0.81–$0.87, opened at $0.86.
- Volume was 43.90K shares, 0.1x its 50-day average of 322.02K — lighter than usual.
- Price is -15.8% vs its 50-day average ($0.97) and -59.6% vs its 200-day average ($2.03).
- 52-week range $0.81–$7.95; today's close sits at 0% of that range, 89.7% below the 52-week high.
Oct 12, 2026 — PRFX dips 2.2% to $0.86
- Closed at $0.86, -2.16% vs the prior close of $0.88. Day range $0.86–$0.92, opened at $0.91.
- Volume was 25.50K shares, 0.1x its 50-day average of 323.93K — lighter than usual.
- Price is -11.8% vs its 50-day average ($0.98) and -57.9% vs its 200-day average ($2.04).
- 52-week range $0.85–$7.95; today's close sits at 0% of that range, 89.2% below the 52-week high.
Oct 9, 2026 — PRFX rises 2.3% to $0.88
- Closed at $0.88, +2.33% vs the prior close of $0.86. Day range $0.86–$0.89, opened at $0.88.
- Volume was 31.80K shares, 0.1x its 50-day average of 327.63K — lighter than usual.
- Price is -10.2% vs its 50-day average ($0.98) and -57.3% vs its 200-day average ($2.06).
- 52-week range $0.85–$7.95; today's close sits at 0% of that range, 88.9% below the 52-week high.
Oct 8, 2026 — PRFX dips 2.2% to $0.86, a 52-week low, 6 down days in a row
- Closed at $0.86, -2.16% vs the prior close of $0.88. Day range $0.85–$0.89, opened at $0.89.
- Volume was 20.50K shares, 0.1x its 50-day average of 339.58K — lighter than usual.
- Price is -12.5% vs its 50-day average ($0.98) and -58.7% vs its 200-day average ($2.08).
- 52-week range $0.85–$7.95; today's close sits at 0% of that range, 89.2% below the 52-week high.
- That makes 6 straight losses.
Oct 7, 2026 — PRFX ends flat (-0.2%) to $0.88, 5 down days in a row
- Closed at $0.88, -0.23% vs the prior close of $0.88. Day range $0.88–$0.89, opened at $0.88.
- Volume was 15.20K shares, 0.0x its 50-day average of 341.29K — lighter than usual.
- Price is -10.8% vs its 50-day average ($0.98) and -58.1% vs its 200-day average ($2.10).
- 52-week range $0.85–$7.95; today's close sits at 0% of that range, 89.0% below the 52-week high.
- That makes 5 straight losses.
Oct 6, 2026 — PRFX dips 0.5% to $0.88, 4 down days in a row
- Closed at $0.88, -0.45% vs the prior close of $0.88. Day range $0.88–$0.93, opened at $0.89.
- Volume was 35.70K shares, 0.1x its 50-day average of 347.31K — lighter than usual.
- Price is -10.9% vs its 50-day average ($0.99) and -58.4% vs its 200-day average ($2.11).
- 52-week range $0.85–$7.95; today's close sits at 0% of that range, 88.9% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 — PRFX slides 3.9% to $0.88, 3 down days in a row
- Closed at $0.88, -3.91% vs the prior close of $0.92. Day range $0.87–$0.93, opened at $0.92.
- Volume was 68.90K shares, 0.2x its 50-day average of 347.87K — lighter than usual.
- Price is -10.9% vs its 50-day average ($0.99) and -58.6% vs its 200-day average ($2.13).
- 52-week range $0.85–$7.95; today's close sits at 0% of that range, 88.9% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — PRFX slides 3.2% to $0.92
- Closed at $0.92, -3.16% vs the prior close of $0.95. Day range $0.91–$0.94, opened at $0.92.
- Volume was 49.90K shares, 0.1x its 50-day average of 348.58K — lighter than usual.
- Price is -7.7% vs its 50-day average ($1.00) and -57.3% vs its 200-day average ($2.15).
- 52-week range $0.85–$7.95; today's close sits at 1% of that range, 88.4% below the 52-week high.
PRFX latest news & SEC filings
Every SEC filing by or about PRFX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 28, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 24, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 16, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 9, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 3, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 27, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 21, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 15, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 8, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 29, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Jun 29, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jun 29, 2026 · Form CORRESP — Company letter to the SEC
Company letter to the SEC
Jun 26, 2026 · Form UPLOAD — SEC staff letter to the company
SEC staff letter to the company
Things to know before you trade PRFX
- How much it moves: over the last 20 sessions the average daily move was 2.64% (largest 7.6%).
- Liquidity: about 48.56K shares (≈$37.94K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.78 vs a range of $0.78–$7.95 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:5 on Feb 6, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Sep 28, 2026; 6-K Sep 16, 2026; 6-K Sep 9, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
PRFX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.81 | 0.83 | 0.78 | 0.78 | 6.72K |
| Oct 15, 2026 | 0.82 | 0.87 | 0.81 | 0.85 | 36.40K |
| Oct 14, 2026 | 0.83 | 0.84 | 0.81 | 0.82 | 55.30K |
| Oct 13, 2026 | 0.86 | 0.87 | 0.81 | 0.82 | 43.90K |
| Oct 12, 2026 | 0.91 | 0.92 | 0.86 | 0.86 | 25.50K |
| Oct 9, 2026 | 0.88 | 0.89 | 0.86 | 0.88 | 31.80K |
| Oct 8, 2026 | 0.89 | 0.89 | 0.85 | 0.86 | 20.50K |
| Oct 7, 2026 | 0.88 | 0.89 | 0.88 | 0.88 | 15.20K |
| Oct 6, 2026 | 0.89 | 0.93 | 0.88 | 0.88 | 35.70K |
| Oct 5, 2026 | 0.92 | 0.93 | 0.87 | 0.88 | 68.90K |
| Oct 2, 2026 | 0.92 | 0.94 | 0.91 | 0.92 | 49.90K |
| Oct 1, 2026 | 0.97 | 0.97 | 0.95 | 0.95 | 22.00K |
| Sep 30, 2026 | 0.97 | 0.98 | 0.95 | 0.95 | 10.20K |
| Sep 29, 2026 | 0.96 | 0.97 | 0.94 | 0.94 | 11.80K |
| Sep 28, 2026 | 0.99 | 1.02 | 0.96 | 0.97 | 41.30K |
| Sep 25, 2026 | 0.99 | 1.02 | 0.95 | 0.98 | 43.10K |
| Sep 24, 2026 | 1.00 | 1.01 | 0.97 | 0.98 | 100.00K |
| Sep 23, 2026 | 0.95 | 1.09 | 0.95 | 1.00 | 164.10K |
| Sep 22, 2026 | 0.98 | 0.99 | 0.90 | 0.93 | 61.90K |
| Sep 21, 2026 | 1.02 | 1.08 | 0.95 | 0.96 | 126.90K |
About PRF Technologies
PRF Technologies (PRFX) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in TEL AVIV. State of incorporation: Israel. Fiscal year ends December 31. SEC CIK 1801834.
PRFX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Ellen S Baron | Director | Mar 18, 2026 |
| Efraim Cohen-Arazi | Interim CEO | Mar 18, 2026 |
| Ehud Geller | Exec Chairman of the Board | Mar 18, 2026 |
| Augustine Lawlor | Director | Mar 18, 2026 |
| Asaf Shavit | Director | Mar 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Sigal Aviel | Chief Operating Officer | Mar 18, 2026 |
| Eyal Broder | Chief Financial Officer | Mar 18, 2026 |
| Efraim Cohen-Arazi | Interim CEO | Mar 18, 2026 |
| Ehud Geller | Exec Chairman of the Board | Mar 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
PRFX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
PRFX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on PRFX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.